New Studies: Pfizer’s Paxlovid doesn’t actually work, ‘rebound’ symptoms occur 25x more often than advertised

Failed drug cost U.S. taxpayers $12.6 billion.

Pfizer first scammed the world with its “100% safe and effective” Covid mRNA vaccines, and as it turns out, that was just the opening salvo from a pharmaceutical cartel that is inundated with corruption and deceit.

I wanted to turn your attention to two significant recent studies on Paxlovid, the Covid-19 oral pill that the U.S. government spent $12.6 billion taxpayer dollars on subsidizing for Pfizer.

The first study, which is brought to you by Pfizer funds (though they noticeably don’t use the brand name Paxlovid in the study), finds that Paxlovid does not actually work. They’ve known this since July, 2022, but for reasons unknown, waited two years to publish the results.

“The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir–ritonavir (Paxlovid) and those who received placebo,” the authors write in this New England Journal of Medicine study, which was published on April 3rd.

That’s right. It doesn’t work at all.

Share
Scroll to Top